Phase III Randomized Trial of Fludarabine and Cyclophosphamide Versus Fludarabine for Previously Untreated Chronic Lymphocytic Leukemia.
Phase of Trial: Phase III
Latest Information Update: 18 May 2018
At a glance
- Drugs Cyclophosphamide (Primary) ; Fludarabine (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 27 Jan 2010 Additional lead trial centre and investigators added as reported by ClinicalTrials.gov.(Parent trial: NCT00003764).
- 01 Mar 2007 Results have been published.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History